Carter Robert Ross 4

What Happened
Carter Robert Ross, Chief Financial Officer of Oncology Institute, disposed of 1,314 shares on March 17, 2026. The shares were sold at $3.59 per share for a total of approximately $4,717. This was a sale (routine sell-to-cover) related to taxes from vested restricted stock units (RSUs), not an open-market investment decision.

Key Details

• Transaction date and price: March 17, 2026 — 1,314 shares sold at $3.59 each.
• Total value: ~ $4,717.
• Transaction code: J (Other acquisition or disposition); footnote F1 states the issuer executed the sale to cover tax liabilities from RSU vesting.
• Shares owned after transaction: Not specified in the provided filing.
• Filing timeliness: Form 4 filed March 18, 2026 (filed promptly the next day).

Context
This was a sell-to-cover to satisfy tax withholding on vested RSUs—a common, administrative transaction for executives. Such tax-related disposals are routine and do not necessarily signal the insider’s view on the company; purchases generally carry more informational weight for investors.